Basic info
Industry
biotechnology research
Sectors
Biotechnology
Chronic wounds
Oncolytic Bacteria
Cell and gene therapy
Therapeutics
Oncology
Inflammation
Advanced Therapy Medicinal Product
Pharmaceutical
Recombinant Live Biotherapeutic
Date founded
2015
Funding rounds raised
Total raised
$10M
from 2 investors over 2 rounds
A
Aurealis Therapeutics raised $10M on March 30, 2023
Investors: Lynx Financial 德石资本 and Tesi (Suomen Teollisuussijoitus)